Romsey, UK; 9 August 2017. Stratophase, the UK-based biopharmaceutical services and technology company, has today announced the appointment of Remy Martin as Business Development Manager.
Remy’s main responsibility will be to build and manage the company’s growing portfolio of Ranger® bioprocessing contract services. He will focus primarily on the European market and report to Stratophase CEO Simon Saxby.
Remy brings to Stratophase a wealth of experience and knowledge of upstream process development, process control and sensor technologies.
He joins the company from the University of Bristol, where he was employed as a Post-Doctoral Research Associate. Prior to that, Remy worked as a Bioreactor Specialist at Applikon Biotechnology UK, providing bespoke bioreactor control solutions.
Remy has a PhD in Biochemistry from the University of Bristol and an MBiol in Molecular & Cellular Biology from the University of Bath.
Commenting on Remy Martin’s appointment, CEO Simon Saxby said: “Remy’s enthusiasm for, and experience in, bioreactor control fit perfectly with the on-going development of Ranger© adaptive control contract services and their take-up by the global biopharma industry”.
ends
About Stratophase
Stratophase is a specialist biopharma services company that is revolutionising the timelines associated with the development and commercialisation of biologics. This is achieved by the adaptive control and optimisation of bioreactor environments using its patented Ranger® optical sensing technology. Ranger is scale-independent and enables cell culture optimisation to be achieved in real-time, through the on-line assessment of metabolic activity. The company has a wealth of application data and expertise, gained through its on-going collaborations with industry leading biopharma innovators. Stratophase was established in 1999 and is based in Romsey, near Southampton, UK. For more information visit: www.stratophase.com
All media enquiries:
Andy Matthews
O2PR
andy.matthews@o2pr.co.uk
Mobile: +44 (0)7967 153753
